| 0 |
DIHYDROTESTOSTERONE DECREASED |
1 |
0.0278 |
| 1 |
PITYRIASIS |
1 |
0.0111 |
| 2 |
INFUSION SITE HYPOAESTHESIA |
1 |
0.0105 |
| 3 |
SLEEP PHASE RHYTHM DISTURBANCE |
1 |
0.0066 |
| 4 |
SENSORY LEVEL ABNORMAL |
1 |
0.0044 |
| 5 |
GENITAL DISORDER FEMALE |
1 |
0.0041 |
| 6 |
TRI-IODOTHYRONINE FREE DECREASED |
1 |
0.0039 |
| 7 |
CHANGE IN SUSTAINED ATTENTION |
1 |
0.0033 |
| 8 |
BLOOD CREATINE PHOSPHOKINASE ABNORMAL |
1 |
0.0022 |
| 9 |
TRACHEAL DISORDER |
1 |
0.0019 |
| 10 |
GADOLINIUM DEPOSITION DISEASE |
1 |
0.0018 |
| 11 |
UTERINE ENLARGEMENT |
1 |
0.0013 |
| 12 |
VITAMIN B12 INCREASED |
1 |
0.0013 |
| 13 |
ORGASM ABNORMAL |
1 |
0.0012 |
| 14 |
PERITONSILLAR ABSCESS |
1 |
0.0012 |
| 15 |
CORONARY ARTERY DISSECTION |
1 |
0.0012 |
| 16 |
DRUG ADMINISTERED IN WRONG DEVICE |
1 |
0.0010 |
| 17 |
UTERINE PAIN |
1 |
0.0010 |
| 18 |
HANGOVER |
3 |
0.0009 |
| 19 |
GESTATIONAL HYPERTENSION |
1 |
0.0008 |
| 20 |
WISDOM TEETH REMOVAL |
1 |
0.0008 |
| 21 |
HEAD TITUBATION |
1 |
0.0007 |
| 22 |
CATAPLEXY |
1 |
0.0007 |
| 23 |
SLEEP PARALYSIS |
1 |
0.0007 |
| 24 |
GENERALISED ANXIETY DISORDER |
1 |
0.0007 |
| 25 |
HYPOAESTHESIA FACIAL |
1 |
0.0007 |
| 26 |
EDUCATIONAL PROBLEM |
1 |
0.0006 |
| 27 |
MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED |
1 |
0.0006 |
| 28 |
DRUG MONITORING PROCEDURE NOT PERFORMED |
1 |
0.0006 |
| 29 |
HYPOGEUSIA |
1 |
0.0005 |
| 30 |
CARDIAC DISCOMFORT |
1 |
0.0005 |
| 31 |
LIBIDO INCREASED |
1 |
0.0005 |
| 32 |
PRE-EXISTING CONDITION IMPROVED |
3 |
0.0005 |
| 33 |
LIVEDO RETICULARIS |
1 |
0.0005 |
| 34 |
PRODUCT LOT NUMBER ISSUE |
1 |
0.0005 |
| 35 |
TEMPERATURE REGULATION DISORDER |
1 |
0.0004 |
| 36 |
FLAT AFFECT |
1 |
0.0004 |
| 37 |
ORAL SURGERY |
1 |
0.0004 |
| 38 |
MEAN CELL VOLUME INCREASED |
1 |
0.0004 |
| 39 |
PERSONALITY DISORDER |
1 |
0.0004 |
| 40 |
ANORGASMIA |
1 |
0.0004 |
| 41 |
CLUMSINESS |
1 |
0.0004 |
| 42 |
PLEURITIC PAIN |
1 |
0.0004 |
| 43 |
DRUG TOLERANCE DECREASED |
1 |
0.0004 |
| 44 |
SKIN HYPERTROPHY |
1 |
0.0004 |
| 45 |
STRIDOR |
1 |
0.0003 |
| 46 |
DRUG EFFECT INCREASED |
1 |
0.0003 |
| 47 |
THERAPEUTIC RESPONSE CHANGED |
2 |
0.0003 |
| 48 |
BLADDER PAIN |
1 |
0.0003 |
| 49 |
MUSCLE CONTRACTIONS INVOLUNTARY |
1 |
0.0003 |
| 50 |
MONOCYTE COUNT INCREASED |
1 |
0.0003 |
| 51 |
PARADOXICAL DRUG REACTION |
1 |
0.0003 |
| 52 |
RECTAL DISCHARGE |
1 |
0.0003 |
| 53 |
PROTEIN TOTAL DECREASED |
1 |
0.0003 |
| 54 |
AUTOIMMUNE THYROIDITIS |
1 |
0.0003 |
| 55 |
PARANASAL SINUS HYPERSECRETION |
1 |
0.0003 |
| 56 |
SELF-MEDICATION |
1 |
0.0002 |
| 57 |
THYROID FUNCTION TEST ABNORMAL |
1 |
0.0002 |
| 58 |
ATTENTION DEFICIT HYPERACTIVITY DISORDER |
1 |
0.0002 |
| 59 |
UTERINE HAEMORRHAGE |
1 |
0.0002 |
| 60 |
CHAPPED LIPS |
1 |
0.0002 |
| 61 |
GROIN PAIN |
2 |
0.0002 |
| 62 |
LUMBAR VERTEBRAL FRACTURE |
1 |
0.0002 |
| 63 |
FEELING OF DESPAIR |
1 |
0.0002 |
| 64 |
SPINAL DISORDER |
2 |
0.0002 |
| 65 |
PRE-ECLAMPSIA |
1 |
0.0002 |
| 66 |
VIRAL UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0002 |
| 67 |
ENDOMETRIOSIS |
1 |
0.0002 |
| 68 |
PETIT MAL EPILEPSY |
1 |
0.0002 |
| 69 |
VARICOSE VEIN |
1 |
0.0002 |
| 70 |
NYSTAGMUS |
1 |
0.0002 |
| 71 |
HIP SURGERY |
1 |
0.0002 |
| 72 |
BIPOLAR DISORDER |
2 |
0.0002 |
| 73 |
HYPERKERATOSIS |
1 |
0.0002 |
| 74 |
HEART RATE ABNORMAL |
1 |
0.0002 |
| 75 |
ANGIOPATHY |
1 |
0.0002 |
| 76 |
EXERCISE TOLERANCE DECREASED |
1 |
0.0002 |
| 77 |
PLATELET COUNT ABNORMAL |
1 |
0.0002 |
| 78 |
BLEPHAROSPASM |
1 |
0.0002 |
| 79 |
SLEEP APNOEA SYNDROME |
3 |
0.0002 |
| 80 |
REFUSAL OF TREATMENT BY PATIENT |
1 |
0.0002 |
| 81 |
POST-TRAUMATIC STRESS DISORDER |
1 |
0.0001 |
| 82 |
PANIC REACTION |
1 |
0.0001 |
| 83 |
MAJOR DEPRESSION |
1 |
0.0001 |
| 84 |
CEREBRAL DISORDER |
1 |
0.0001 |
| 85 |
DISSOCIATION |
1 |
0.0001 |
| 86 |
ATRIOVENTRICULAR BLOCK |
1 |
0.0001 |
| 87 |
APHTHOUS ULCER |
1 |
0.0001 |
| 88 |
AFFECTIVE DISORDER |
1 |
0.0001 |
| 89 |
SENSORY DISTURBANCE |
2 |
0.0001 |
| 90 |
SENSORY LOSS |
1 |
0.0001 |
| 91 |
HYPERAESTHESIA |
1 |
0.0001 |
| 92 |
SPINAL COMPRESSION FRACTURE |
1 |
0.0001 |
| 93 |
RESPIRATORY RATE INCREASED |
1 |
0.0001 |
| 94 |
LOSS OF LIBIDO |
1 |
0.0001 |
| 95 |
LIP DRY |
1 |
0.0001 |
| 96 |
GRAND MAL CONVULSION |
1 |
0.0001 |
| 97 |
COGNITIVE DISORDER |
5 |
0.0001 |
| 98 |
PRODUCT SUBSTITUTION ISSUE |
6 |
0.0001 |
| 99 |
ORAL HERPES |
2 |
0.0001 |
| 100 |
OVARIAN CYST |
1 |
0.0001 |
| 101 |
BRAIN INJURY |
1 |
0.0001 |
| 102 |
FEEDING DISORDER |
2 |
0.0001 |
| 103 |
INITIAL INSOMNIA |
1 |
0.0001 |
| 104 |
TOOTH LOSS |
2 |
0.0001 |
| 105 |
RENAL PAIN |
1 |
0.0001 |
| 106 |
BODY HEIGHT DECREASED |
1 |
0.0001 |
| 107 |
DECREASED ACTIVITY |
1 |
0.0001 |
| 108 |
ASPIRATION |
1 |
0.0001 |
| 109 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
1 |
0.0001 |
| 110 |
VENTRICULAR FIBRILLATION |
1 |
0.0001 |
| 111 |
TOOTH DISORDER |
2 |
0.0001 |
| 112 |
IMPAIRED DRIVING ABILITY |
1 |
0.0001 |
| 113 |
DERMATITIS CONTACT |
1 |
0.0001 |
| 114 |
EYELID OEDEMA |
1 |
0.0001 |
| 115 |
POST PROCEDURAL HAEMORRHAGE |
1 |
0.0001 |
| 116 |
SPINAL PAIN |
1 |
0.0001 |
| 117 |
SEXUAL DYSFUNCTION |
1 |
0.0001 |
| 118 |
ATAXIA |
1 |
0.0001 |
| 119 |
MACULAR DEGENERATION |
1 |
0.0001 |
| 120 |
HYPERLIPIDAEMIA |
1 |
0.0001 |
| 121 |
POLYNEUROPATHY |
1 |
0.0001 |
| 122 |
THYROID CANCER |
1 |
0.0001 |
| 123 |
SCHIZOPHRENIA |
1 |
0.0001 |
| 124 |
FIBROMYALGIA |
2 |
0.0001 |
| 125 |
NEURALGIA |
2 |
0.0001 |
| 126 |
RESTLESSNESS |
3 |
0.0001 |
| 127 |
TENDON RUPTURE |
1 |
0.0001 |
| 128 |
ERECTILE DYSFUNCTION |
2 |
0.0001 |
| 129 |
ANOREXIA |
1 |
0.0001 |
| 130 |
ANHEDONIA |
2 |
0.0001 |
| 131 |
IMMUNE SYSTEM DISORDER |
1 |
0.0001 |
| 132 |
FEAR |
2 |
0.0001 |
| 133 |
GINGIVAL BLEEDING |
1 |
0.0001 |
| 134 |
CENTRAL NERVOUS SYSTEM LESION |
1 |
0.0001 |
| 135 |
POLLAKIURIA |
3 |
0.0001 |
| 136 |
HUNGER |
1 |
0.0001 |
| 137 |
NECK PAIN |
4 |
0.0001 |
| 138 |
WITHDRAWAL SYNDROME |
3 |
0.0001 |
| 139 |
PARALYSIS |
1 |
0.0001 |
| 140 |
COMPLICATION ASSOCIATED WITH DEVICE |
1 |
0.0001 |
| 141 |
HAEMORRHAGE INTRACRANIAL |
1 |
0.0001 |
| 142 |
THERAPEUTIC RESPONSE UNEXPECTED |
3 |
0.0001 |
| 143 |
BLOOD COUNT ABNORMAL |
1 |
0.0001 |
| 144 |
SUICIDAL IDEATION |
6 |
0.0001 |
| 145 |
BLOOD CHOLESTEROL INCREASED |
3 |
0.0001 |
| 146 |
BRAIN FOG |
1 |
0.0001 |
| 147 |
MIGRAINE |
6 |
0.0001 |
| 148 |
OBESITY |
1 |
0.0001 |
| 149 |
MUSCLE TIGHTNESS |
1 |
0.0001 |
| 150 |
BACK DISORDER |
1 |
0.0001 |
| 151 |
MANIA |
1 |
0.0001 |
| 152 |
VIRAL INFECTION |
2 |
0.0001 |
| 153 |
ANXIETY |
17 |
0.0001 |
| 154 |
BLOOD UREA INCREASED |
1 |
0.0001 |
| 155 |
TYPE 2 DIABETES MELLITUS |
2 |
0.0001 |
| 156 |
SCAR |
1 |
0.0001 |
| 157 |
GASTRIC DISORDER |
2 |
0.0001 |
| 158 |
MUSCULOSKELETAL DISCOMFORT |
1 |
0.0001 |
| 159 |
NEUROTOXICITY |
1 |
0.0001 |
| 160 |
AMENORRHOEA |
1 |
0.0001 |
| 161 |
DRUG EFFECT DECREASED |
3 |
0.0001 |
| 162 |
PANIC ATTACK |
2 |
0.0001 |
| 163 |
THINKING ABNORMAL |
1 |
0.0001 |
| 164 |
DEPRESSION |
12 |
0.0001 |
| 165 |
FEELING JITTERY |
1 |
0.0001 |
| 166 |
INCREASED APPETITE |
1 |
0.0001 |
| 167 |
PULMONARY FIBROSIS |
1 |
0.0001 |
| 168 |
SEROTONIN SYNDROME |
1 |
0.0001 |
| 169 |
GLAUCOMA |
1 |
0.0001 |
| 170 |
EAR PAIN |
1 |
0.0001 |
| 171 |
SKIN FISSURES |
1 |
0.0001 |
| 172 |
MENORRHAGIA |
1 |
0.0001 |
| 173 |
INTENTIONAL SELF-INJURY |
1 |
0.0000 |
| 174 |
RETCHING |
1 |
0.0000 |
| 175 |
IMPAIRED WORK ABILITY |
1 |
0.0000 |
| 176 |
AMNESIA |
3 |
0.0000 |
| 177 |
BLOOD PRESSURE DECREASED |
3 |
0.0000 |
| 178 |
PARAESTHESIA |
7 |
0.0000 |
| 179 |
MEMORY IMPAIRMENT |
6 |
0.0000 |
| 180 |
SLEEP DISORDER |
3 |
0.0000 |
| 181 |
OCULAR HYPERAEMIA |
2 |
0.0000 |
| 182 |
FEELING ABNORMAL |
10 |
0.0000 |
| 183 |
MENTAL IMPAIRMENT |
1 |
0.0000 |
| 184 |
HOT FLUSH |
3 |
0.0000 |
| 185 |
ABDOMINAL PAIN LOWER |
1 |
0.0000 |
| 186 |
PRODUCT COMPLAINT |
1 |
0.0000 |
| 187 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
1 |
0.0000 |
| 188 |
RASH GENERALISED |
1 |
0.0000 |
| 189 |
PHARMACEUTICAL PRODUCT COMPLAINT |
1 |
0.0000 |
| 190 |
DIPLOPIA |
1 |
0.0000 |
| 191 |
NERVOUSNESS |
2 |
0.0000 |
| 192 |
MUSCULOSKELETAL PAIN |
2 |
0.0000 |
| 193 |
GASTRITIS |
1 |
0.0000 |
| 194 |
EAR INFECTION |
1 |
0.0000 |
| 195 |
DISTURBANCE IN ATTENTION |
2 |
0.0000 |
| 196 |
THROAT TIGHTNESS |
1 |
0.0000 |
| 197 |
MOOD ALTERED |
1 |
0.0000 |
| 198 |
FEELING COLD |
1 |
0.0000 |
| 199 |
INCORRECT DRUG ADMINISTRATION DURATION |
1 |
0.0000 |
| 200 |
PAIN IN JAW |
1 |
0.0000 |
| 201 |
FLATULENCE |
2 |
0.0000 |
| 202 |
RED BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 203 |
ANGINA PECTORIS |
1 |
0.0000 |
| 204 |
DYSSTASIA |
1 |
0.0000 |
| 205 |
MUSCULOSKELETAL STIFFNESS |
3 |
0.0000 |
| 206 |
SURGERY |
2 |
0.0000 |
| 207 |
ASCITES |
1 |
0.0000 |
| 208 |
URINARY INCONTINENCE |
1 |
0.0000 |
| 209 |
BLOOD POTASSIUM DECREASED |
1 |
0.0000 |
| 210 |
THERAPEUTIC RESPONSE DECREASED |
2 |
0.0000 |
| 211 |
VERTIGO |
2 |
0.0000 |
| 212 |
EMOTIONAL DISORDER |
1 |
0.0000 |
| 213 |
LIMB DISCOMFORT |
1 |
0.0000 |
| 214 |
HYPOTHYROIDISM |
1 |
0.0000 |
| 215 |
NIGHT SWEATS |
1 |
0.0000 |
| 216 |
EYE DISORDER |
1 |
0.0000 |
| 217 |
INSOMNIA |
8 |
0.0000 |
| 218 |
LIP SWELLING |
1 |
0.0000 |
| 219 |
GAIT INABILITY |
1 |
0.0000 |
| 220 |
PRODUCT QUALITY ISSUE |
4 |
0.0000 |
| 221 |
DRUG EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 222 |
VISION BLURRED |
4 |
0.0000 |
| 223 |
HEART RATE DECREASED |
1 |
0.0000 |
| 224 |
LYMPHADENOPATHY |
1 |
0.0000 |
| 225 |
PRODUCT ADHESION ISSUE |
1 |
0.0000 |
| 226 |
DRUG EFFECT INCOMPLETE |
1 |
0.0000 |
| 227 |
CRYING |
1 |
0.0000 |
| 228 |
DYSURIA |
1 |
0.0000 |
| 229 |
INJECTION SITE MASS |
1 |
0.0000 |
| 230 |
DYSGEUSIA |
2 |
0.0000 |
| 231 |
PALPITATIONS |
3 |
0.0000 |
| 232 |
DISORIENTATION |
1 |
0.0000 |
| 233 |
SOMNOLENCE |
5 |
0.0000 |
| 234 |
BLINDNESS |
1 |
0.0000 |
| 235 |
OSTEOPOROSIS |
1 |
0.0000 |
| 236 |
ROAD TRAFFIC ACCIDENT |
1 |
0.0000 |
| 237 |
RENAL IMPAIRMENT |
2 |
0.0000 |
| 238 |
MENTAL DISORDER |
1 |
0.0000 |
| 239 |
INTENTIONAL PRODUCT USE ISSUE |
2 |
0.0000 |
| 240 |
THROAT IRRITATION |
1 |
0.0000 |
| 241 |
TINNITUS |
1 |
0.0000 |
| 242 |
UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 243 |
CHEST PAIN |
4 |
0.0000 |
| 244 |
DECREASED APPETITE |
5 |
0.0000 |
| 245 |
MULTIPLE SCLEROSIS |
1 |
0.0000 |
| 246 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
0.0000 |
| 247 |
CONTUSION |
2 |
0.0000 |
| 248 |
FATIGUE |
16 |
0.0000 |
| 249 |
LUNG DISORDER |
1 |
0.0000 |
| 250 |
HYPOAESTHESIA |
3 |
0.0000 |
| 251 |
AGGRESSION |
1 |
0.0000 |
| 252 |
CONDITION AGGRAVATED |
6 |
0.0000 |
| 253 |
HAEMOGLOBIN DECREASED |
2 |
0.0000 |
| 254 |
PERIPHERAL SWELLING |
3 |
0.0000 |
| 255 |
ABDOMINAL PAIN UPPER |
4 |
0.0000 |
| 256 |
NAUSEA |
15 |
0.0000 |
| 257 |
DRUG INTERACTION |
3 |
0.0000 |
| 258 |
ASTHENIA |
7 |
0.0000 |
| 259 |
CONFUSIONAL STATE |
3 |
0.0000 |
| 260 |
DEPENDENCE |
1 |
0.0000 |
| 261 |
ARTHROPATHY |
1 |
0.0000 |
| 262 |
ABDOMINAL DISCOMFORT |
3 |
0.0000 |
| 263 |
URINARY TRACT INFECTION |
3 |
0.0000 |
| 264 |
CONVULSION |
1 |
0.0000 |
| 265 |
HERPES ZOSTER |
1 |
0.0000 |
| 266 |
LETHARGY |
1 |
0.0000 |
| 267 |
BLADDER CANCER |
1 |
0.0000 |
| 268 |
SUICIDE ATTEMPT |
1 |
0.0000 |
| 269 |
MUSCLE SPASMS |
3 |
0.0000 |
| 270 |
FEELING HOT |
1 |
0.0000 |
| 271 |
NASOPHARYNGITIS |
3 |
0.0000 |
| 272 |
VISUAL IMPAIRMENT |
2 |
0.0000 |
| 273 |
EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 274 |
HEADACHE |
10 |
0.0000 |
| 275 |
INTENTIONAL OVERDOSE |
1 |
0.0000 |
| 276 |
HYPERHIDROSIS |
2 |
0.0000 |
| 277 |
RHINORRHOEA |
1 |
0.0000 |
| 278 |
SWELLING FACE |
1 |
0.0000 |
| 279 |
BLOOD CREATININE INCREASED |
1 |
0.0000 |
| 280 |
PSORIASIS |
2 |
0.0000 |
| 281 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
3 |
0.0000 |
| 282 |
MULTIPLE SCLEROSIS RELAPSE |
1 |
0.0000 |
| 283 |
BURNING SENSATION |
1 |
0.0000 |
| 284 |
DIZZINESS |
7 |
0.0000 |
| 285 |
RESPIRATORY FAILURE |
1 |
0.0000 |
| 286 |
UNDERDOSE |
1 |
0.0000 |
| 287 |
AGITATION |
1 |
0.0000 |
| 288 |
HALLUCINATION |
1 |
0.0000 |
| 289 |
UNEVALUABLE EVENT |
1 |
0.0000 |
| 290 |
BLOOD PRESSURE INCREASED |
2 |
0.0000 |
| 291 |
PAIN |
8 |
0.0000 |
| 292 |
INJECTION SITE BRUISING |
1 |
0.0000 |
| 293 |
GASTROOESOPHAGEAL REFLUX DISEASE |
1 |
0.0000 |
| 294 |
DRY MOUTH |
1 |
0.0000 |
| 295 |
TREMOR |
2 |
0.0000 |
| 296 |
BALANCE DISORDER |
1 |
0.0000 |
| 297 |
MALAISE |
5 |
0.0000 |
| 298 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 299 |
ADVERSE EVENT |
1 |
0.0000 |
| 300 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 301 |
WEIGHT DECREASED |
3 |
0.0000 |
| 302 |
COUGH |
3 |
0.0000 |
| 303 |
CARDIAC DISORDER |
1 |
0.0000 |
| 304 |
PRODUCT USE ISSUE |
2 |
0.0000 |
| 305 |
DYSPHAGIA |
1 |
0.0000 |
| 306 |
NEUROPATHY PERIPHERAL |
1 |
0.0000 |
| 307 |
GAIT DISTURBANCE |
2 |
0.0000 |
| 308 |
ATRIAL FIBRILLATION |
1 |
0.0000 |
| 309 |
ALOPECIA |
2 |
0.0000 |
| 310 |
PAIN IN EXTREMITY |
3 |
0.0000 |
| 311 |
DYSPEPSIA |
1 |
0.0000 |
| 312 |
HEART RATE INCREASED |
1 |
0.0000 |
| 313 |
CHEST DISCOMFORT |
1 |
0.0000 |
| 314 |
ARTHRALGIA |
4 |
0.0000 |
| 315 |
ABDOMINAL DISTENSION |
1 |
0.0000 |
| 316 |
HYPERTENSION |
2 |
0.0000 |
| 317 |
FALL |
3 |
0.0000 |
| 318 |
INFLUENZA |
1 |
0.0000 |
| 319 |
SEPSIS |
1 |
0.0000 |
| 320 |
WEIGHT INCREASED |
2 |
0.0000 |
| 321 |
MUSCULAR WEAKNESS |
1 |
0.0000 |
| 322 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 323 |
BACK PAIN |
2 |
0.0000 |
| 324 |
ABDOMINAL PAIN |
2 |
0.0000 |
| 325 |
DRUG INEFFECTIVE |
11 |
0.0000 |
| 326 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 327 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 328 |
DIARRHOEA |
5 |
0.0000 |
| 329 |
DEHYDRATION |
1 |
0.0000 |
| 330 |
INFECTION |
1 |
0.0000 |
| 331 |
VOMITING |
3 |
0.0000 |
| 332 |
DRUG DOSE OMISSION |
1 |
0.0000 |
| 333 |
TOXICITY TO VARIOUS AGENTS |
1 |
0.0000 |
| 334 |
MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 335 |
NO ADVERSE EVENT |
1 |
0.0000 |
| 336 |
HYPERSENSITIVITY |
1 |
0.0000 |
| 337 |
ANAEMIA |
1 |
0.0000 |
| 338 |
HYPOTENSION |
1 |
0.0000 |
| 339 |
ERYTHEMA |
1 |
0.0000 |
| 340 |
INCORRECT DOSE ADMINISTERED |
1 |
0.0000 |
| 341 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
0.0000 |
| 342 |
DYSPNOEA |
2 |
0.0000 |
| 343 |
PNEUMONIA |
1 |
0.0000 |
| 344 |
PYREXIA |
1 |
0.0000 |
| 345 |
PRURITUS |
1 |
0.0000 |
| 346 |
OFF LABEL USE |
2 |
0.0000 |
| 347 |
DEATH |
1 |
0.0000 |